Neuroleptics as a guideline to biological research in psychotic disorders.
D000661:Amphetamine; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D003863:Depression / Q000188:drug therapy; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007980:Levodopa; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D011605:Psychoses, Substance-Induced; D011618:Psychotic Disorders / Q000188:drug therapy / Q000378:metabolism; D011817:Rabbits; D011955:Receptors, Drug; D012106:Research; D012107:Research Design; D014149:Tranquilizing Agents / Q000494:pharmacology* / Q000627:therapeutic use
D000928:Antidepressive Agents; D002395:Catecholamines; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D007980:Levodopa; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine